25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Immunic Inc
Buy, Hold or Sell?

Let's analyze Immunic Inc together

I guess you are interested in Immunic Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Immunic Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Immunic Inc

I send you an email if I find something interesting about Immunic Inc.

1. Quick Overview

1.1. Quick analysis of Immunic Inc (30 sec.)










1.2. What can you expect buying and holding a share of Immunic Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.44
Expected worth in 1 year
€0.36
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
€-0.08
Return On Investment
-7.1%

For what price can you sell your share?

Current Price per Share
€1.08
Expected price per share
€0.88 - €1.124
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Immunic Inc (5 min.)




Live pricePrice per Share (EOD)
€1.08
Intrinsic Value Per Share
€-7.51 - €-8.70
Total Value Per Share
€-7.07 - €-8.27

2.2. Growth of Immunic Inc (5 min.)




Is Immunic Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$41.2m$80.6m-$26.3m-48.5%

How much money is Immunic Inc making?

Current yearPrevious yearGrowGrow %
Making money-$24.2m-$32.1m$7.9m32.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Immunic Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#458 / 922

Most Revenue
#836 / 922

Most Profit
#689 / 922

Most Efficient
#176 / 922
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Immunic Inc?

Welcome investor! Immunic Inc's management wants to use your money to grow the business. In return you get a share of Immunic Inc.

First you should know what it really means to hold a share of Immunic Inc. And how you can make/lose money.

Speculation

The Price per Share of Immunic Inc is €1.079. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Immunic Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Immunic Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.44. Based on the TTM, the Book Value Change Per Share is €-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Immunic Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.27-25.1%-0.27-24.9%-0.35-32.7%-0.24-22.3%-0.23-21.6%
Usd Book Value Change Per Share-0.25-23.0%-0.02-1.8%-0.17-15.5%-0.01-1.0%0.022.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.25-23.0%-0.02-1.8%-0.17-15.5%-0.01-1.0%0.022.0%
Usd Price Per Share1.42-1.28-1.64-6.37-6.55-
Price to Earnings Ratio-1.31--1.21--1.37--9.62--10.48-
Price-to-Total Gains Ratio-5.72--3.74-0.77--40.47--37.83-
Price to Book Ratio3.10-2.60-2.05-5.67-6.11-
Price-to-Total Gains Ratio-5.72--3.74-0.77--40.47--37.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1288498
Number of shares885
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.02-0.01
Gains per Quarter (885 shares)-17.65-9.48
Gains per Year (885 shares)-70.62-37.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-71-810-38-48
20-141-1520-76-86
30-212-2230-114-124
40-282-2940-152-162
50-353-3650-190-200
60-424-4360-228-238
70-494-5070-266-276
80-565-5780-304-314
90-636-6490-341-352
100-706-7200-379-390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.021.00.00.0%0.021.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%7.014.00.033.3%7.014.00.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%7.014.00.033.3%7.014.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Immunic Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.237-0.019-92%-0.160-32%-0.010-96%0.021-1239%
Book Value Per Share--0.4370.576-24%0.856-49%1.037-58%1.018-57%
Current Ratio--2.7093.418-21%6.144-56%7.468-64%7.346-63%
Debt To Asset Ratio--0.3640.323+12%0.192+89%0.157+132%0.154+135%
Debt To Equity Ratio--0.5710.514+11%0.245+133%0.211+170%0.207+176%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--99644746.29688547394.393+13%124273570.775-20%534699387.194-81%550308852.251-82%
Eps---0.259-0.257-1%-0.338+31%-0.230-11%-0.223-14%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.221-0.202-9%-0.191-14%-0.183-17%-0.183-17%
Free Cash Flow To Equity Per Share---0.221-0.003-99%-0.041-81%0.095-332%0.095-332%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.704--------
Intrinsic Value_10Y_min---7.510--------
Intrinsic Value_1Y_max---0.799--------
Intrinsic Value_1Y_min---0.785--------
Intrinsic Value_3Y_max---2.457--------
Intrinsic Value_3Y_min---2.345--------
Intrinsic Value_5Y_max---4.182--------
Intrinsic Value_5Y_min---3.877--------
Market Cap97195241.000-26%122147145.696110628285.993+10%140939855.375-13%548738751.074-78%564001779.594-78%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio2.467-26%3.1002.601+19%2.048+51%5.666-45%6.112-49%
Pe Ratio-1.043+20%-1.311-1.213-7%-1.374+5%-9.616+633%-10.476+699%
Price Per Share1.079-26%1.3561.228+10%1.565-13%6.092-78%6.261-78%
Price To Free Cash Flow Ratio-1.219+20%-1.532-1.585+3%-2.032+33%-9.093+494%-8.660+465%
Price To Total Gains Ratio-4.549+20%-5.717-3.738-35%0.774-839%-40.474+608%-37.831+562%
Quick Ratio----0%0.302-100%0.190-100%0.181-100%
Return On Assets---0.376-0.326-13%-0.321-15%-0.211-44%-0.207-45%
Return On Equity---0.591-0.507-14%-0.398-33%-0.271-54%-0.265-55%
Total Gains Per Share---0.237-0.019-92%-0.160-32%-0.010-96%0.021-1239%
Usd Book Value--41217267.15354322466.188-24%80644859.548-49%97719641.694-58%95948442.348-57%
Usd Book Value Change Per Share---0.248-0.020-92%-0.168-32%-0.011-96%0.022-1239%
Usd Book Value Per Share--0.4580.603-24%0.895-49%1.085-58%1.065-57%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--104248333.57592638284.014+13%130015009.745-20%559402498.882-81%575733121.225-82%
Usd Eps---0.271-0.269-1%-0.353+31%-0.240-11%-0.233-14%
Usd Free Cash Flow---20852123.340-19063198.549-9%-18017492.513-14%-16401910.435-21%-15620867.081-25%
Usd Free Cash Flow Per Share---0.231-0.212-9%-0.200-14%-0.192-17%-0.192-17%
Usd Free Cash Flow To Equity Per Share---0.231-0.003-99%-0.043-81%0.100-332%0.100-332%
Usd Market Cap101685661.134-26%127790343.827115739312.806+10%147451276.693-13%574090481.373-78%590058661.811-78%
Usd Price Per Share1.129-26%1.4191.285+10%1.637-13%6.373-78%6.550-78%
Usd Profit---24366975.569-24224981.539-1%-32127149.318+32%-21699287.724-11%-21057162.339-14%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.248-0.020-92%-0.168-32%-0.011-96%0.022-1239%
 EOD+3 -5MRQTTM+6 -24YOY+4 -275Y+3 -2810Y+3 -28

3.3 Fundamental Score

Let's check the fundamental score of Immunic Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.043
Price to Book Ratio (EOD)Between0-12.467
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.709
Debt to Asset Ratio (MRQ)Less than10.364
Debt to Equity Ratio (MRQ)Less than10.571
Return on Equity (MRQ)Greater than0.15-0.591
Return on Assets (MRQ)Greater than0.05-0.376
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Immunic Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.801
Ma 20Greater thanMa 500.944
Ma 50Greater thanMa 1001.008
Ma 100Greater thanMa 2001.125
OpenGreater thanClose0.948
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Immunic Inc

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-02-21 17:27:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Immunic Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Immunic Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Immunic Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--99.4%+99.4%
TTM--211.5%+211.5%
YOY--210.1%+210.1%
5Y--346.2%+346.2%
10Y--489.2%+489.2%
4.3.1.2. Return on Assets

Shows how efficient Immunic Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Immunic Inc to the Biotechnology industry mean.
  • -37.6% Return on Assets means that Immunic Inc generated €-0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Immunic Inc:

  • The MRQ is -37.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -32.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.6%TTM-32.6%-5.0%
TTM-32.6%YOY-32.1%-0.5%
TTM-32.6%5Y-21.1%-11.5%
5Y-21.1%10Y-20.7%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.6%-12.0%-25.6%
TTM-32.6%-12.1%-20.5%
YOY-32.1%-11.4%-20.7%
5Y-21.1%-12.8%-8.3%
10Y-20.7%-14.5%-6.2%
4.3.1.3. Return on Equity

Shows how efficient Immunic Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Immunic Inc to the Biotechnology industry mean.
  • -59.1% Return on Equity means Immunic Inc generated €-0.59 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Immunic Inc:

  • The MRQ is -59.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -50.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.1%TTM-50.7%-8.4%
TTM-50.7%YOY-39.8%-10.9%
TTM-50.7%5Y-27.1%-23.5%
5Y-27.1%10Y-26.5%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.1%-15.4%-43.7%
TTM-50.7%-16.1%-34.6%
YOY-39.8%-14.7%-25.1%
5Y-27.1%-18.5%-8.6%
10Y-26.5%-19.5%-7.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Immunic Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Immunic Inc is operating .

  • Measures how much profit Immunic Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Immunic Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Immunic Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--202.6%+202.6%
TTM--313.2%+313.2%
YOY--214.2%+214.2%
5Y--371.8%+371.8%
10Y--492.1%+492.1%
4.3.2.2. Operating Ratio

Measures how efficient Immunic Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Immunic Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.129-2.129
TTM-3.198-3.198
YOY-3.358-3.358
5Y-4.842-4.842
10Y-6.500-6.500
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Immunic Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Immunic Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.71 means the company has €2.71 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Immunic Inc:

  • The MRQ is 2.709. The company is able to pay all its short-term debts. +1
  • The TTM is 3.418. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.709TTM3.418-0.710
TTM3.418YOY6.144-2.726
TTM3.4185Y7.468-4.049
5Y7.46810Y7.346+0.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7093.608-0.899
TTM3.4183.871-0.453
YOY6.1444.591+1.553
5Y7.4685.971+1.497
10Y7.3466.216+1.130
4.4.3.2. Quick Ratio

Measures if Immunic Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Immunic Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Immunic Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.302-0.302
TTM-5Y0.190-0.190
5Y0.19010Y0.181+0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.075-3.075
TTM-3.351-3.351
YOY0.3024.393-4.091
5Y0.1905.972-5.782
10Y0.1816.463-6.282
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Immunic Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Immunic Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Immunic Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Immunic Inc assets are financed with 36.4% credit (debt) and the remaining percentage (100% - 36.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Immunic Inc:

  • The MRQ is 0.364. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.323. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.323+0.040
TTM0.323YOY0.192+0.131
TTM0.3235Y0.157+0.166
5Y0.15710Y0.154+0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3640.342+0.022
TTM0.3230.345-0.022
YOY0.1920.315-0.123
5Y0.1570.363-0.206
10Y0.1540.384-0.230
4.5.4.2. Debt to Equity Ratio

Measures if Immunic Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Immunic Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 57.1% means that company has €0.57 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Immunic Inc:

  • The MRQ is 0.571. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.514. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.571TTM0.514+0.057
TTM0.514YOY0.245+0.268
TTM0.5145Y0.211+0.302
5Y0.21110Y0.207+0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5710.387+0.184
TTM0.5140.428+0.086
YOY0.2450.391-0.146
5Y0.2110.450-0.239
10Y0.2070.495-0.288
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Immunic Inc generates.

  • Above 15 is considered overpriced but always compare Immunic Inc to the Biotechnology industry mean.
  • A PE ratio of -1.31 means the investor is paying €-1.31 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Immunic Inc:

  • The EOD is -1.043. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.311. Based on the earnings, the company is expensive. -2
  • The TTM is -1.213. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.043MRQ-1.311+0.268
MRQ-1.311TTM-1.213-0.098
TTM-1.213YOY-1.374+0.161
TTM-1.2135Y-9.616+8.403
5Y-9.61610Y-10.476+0.860
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.043-2.261+1.218
MRQ-1.311-2.752+1.441
TTM-1.213-3.224+2.011
YOY-1.374-3.405+2.031
5Y-9.616-6.128-3.488
10Y-10.476-6.735-3.741
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Immunic Inc:

  • The EOD is -1.219. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.532. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.585. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.219MRQ-1.532+0.313
MRQ-1.532TTM-1.585+0.053
TTM-1.585YOY-2.032+0.447
TTM-1.5855Y-9.093+7.508
5Y-9.09310Y-8.660-0.433
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.219-3.073+1.854
MRQ-1.532-3.602+2.070
TTM-1.585-3.827+2.242
YOY-2.032-4.448+2.416
5Y-9.093-8.209-0.884
10Y-8.660-9.216+0.556
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Immunic Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.10 means the investor is paying €3.10 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Immunic Inc:

  • The EOD is 2.467. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.100. Based on the equity, the company is fair priced.
  • The TTM is 2.601. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.467MRQ3.100-0.633
MRQ3.100TTM2.601+0.500
TTM2.601YOY2.048+0.553
TTM2.6015Y5.666-3.065
5Y5.66610Y6.112-0.446
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4671.942+0.525
MRQ3.1002.252+0.848
TTM2.6012.427+0.174
YOY2.0482.470-0.422
5Y5.6663.770+1.896
10Y6.1124.507+1.605
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets64,762
Total Liabilities23,543
Total Stockholder Equity41,219
 As reported
Total Liabilities 23,543
Total Stockholder Equity+ 41,219
Total Assets = 64,762

Assets

Total Assets64,762
Total Current Assets63,266
Long-term Assets1,496
Total Current Assets
Cash And Cash Equivalents 59,071
Other Current Assets 757
Total Current Assets  (as reported)63,266
Total Current Assets  (calculated)59,828
+/- 3,438
Long-term Assets
Property Plant Equipment 1,496
Long-term Assets  (as reported)1,496
Long-term Assets  (calculated)1,496
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities23,357
Long-term Liabilities186
Total Stockholder Equity41,219
Total Current Liabilities
Accounts payable 5,789
Other Current Liabilities 357
Total Current Liabilities  (as reported)23,357
Total Current Liabilities  (calculated)6,146
+/- 17,211
Long-term Liabilities
Long-term Liabilities  (as reported)186
Long-term Liabilities  (calculated)0
+/- 186
Total Stockholder Equity
Total Stockholder Equity (as reported)41,219
Total Stockholder Equity (calculated)0
+/- 41,219
Other
Capital Stock8
Common Stock Shares Outstanding 90,079
Net Invested Capital 41,219
Net Working Capital 39,909
Property Plant and Equipment Gross 1,496



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
67,604
65,955
57,292
87,152
171,640
167,861
154,724
136,058
156,757
139,100
149,920
138,657
121,083
127,753
108,872
88,739
66,977
54,299
104,155
86,491
64,762
64,76286,491104,15554,29966,97788,739108,872127,753121,083138,657149,920139,100156,757136,058154,724167,861171,64087,15257,29265,95567,604
   > Total Current Assets 
34,519
32,230
23,599
53,023
137,541
133,745
120,280
101,687
122,495
104,988
115,879
104,761
86,649
125,864
106,582
86,551
65,234
52,534
102,615
84,978
63,266
63,26684,978102,61552,53465,23486,551106,582125,86486,649104,761115,879104,988122,495101,687120,280133,745137,54153,02323,59932,23034,519
       Cash And Cash Equivalents 
30,460
29,369
18,578
48,607
133,183
127,452
114,839
87,175
110,444
86,863
95,710
88,078
72,771
106,745
92,761
77,294
59,689
46,674
97,312
79,698
59,071
59,07179,69897,31246,67459,68977,29492,761106,74572,77188,07895,71086,863110,44487,175114,839127,452133,18348,60718,57829,36930,460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,629
4,351
0
0
0
0
0
0
0000004,3519,6290000000000000
       Net Receivables 
0
758
641
1,083
1,108
1,643
1,998
6,406
2,904
2,150
3,215
3,272
3,391
2,657
0
0
0
0
0
0
0
00000002,6573,3913,2723,2152,1502,9046,4061,9981,6431,1081,0836417580
       Other Current Assets 
4,059
2,861
670
655
597
6,293
5,441
1,496
12,051
1,122
1,548
16,683
13,878
1,225
1,902
9,257
1,447
2,173
1,090
1,057
757
7571,0571,0902,1731,4479,2571,9021,22513,87816,6831,5481,12212,0511,4965,4416,2935976556702,8614,059
   > Long-term Assets 
33,085
33,725
33,693
34,129
34,099
34,116
34,444
34,371
34,262
34,112
34,041
33,896
34,434
1,889
2,290
2,188
1,743
1,765
1,540
1,513
1,496
1,4961,5131,5401,7651,7432,1882,2901,88934,43433,89634,04134,11234,26234,37134,44434,11634,09934,12933,69333,72533,085
       Property Plant Equipment 
115
713
681
1,117
1,087
1,104
1,432
1,359
1,250
1,100
1,029
884
1,422
1,846
2,247
2,145
1,700
1,765
1,540
1,513
1,496
1,4961,5131,5401,7651,7002,1452,2471,8461,4228841,0291,1001,2501,3591,4321,1041,0871,117681713115
       Goodwill 
32,970
32,970
32,970
32,970
32,970
32,970
32,970
32,970
32,970
32,970
32,970
32,970
32,970
0
0
0
0
0
0
0
0
0000000032,97032,97032,97032,97032,97032,97032,97032,97032,97032,97032,97032,97032,970
       Other Assets 
0
42
42
42
42
42
42
42
42
42
42
42
42
43
0
43
0
0
0
0
0
00000430434242424242424242424242420
> Total Liabilities 
7,077
7,592
6,804
8,467
8,765
9,076
17,278
15,316
11,292
11,985
11,959
10,809
12,273
14,069
17,654
19,455
18,570
25,368
20,579
22,918
23,543
23,54322,91820,57925,36818,57019,45517,65414,06912,27310,80911,95911,98511,29215,31617,2789,0768,7658,4676,8047,5927,077
   > Total Current Liabilities 
7,036
7,072
6,333
7,674
8,030
8,397
16,356
14,487
10,591
11,401
11,457
10,402
11,514
13,077
16,302
18,241
17,781
24,729
20,146
22,677
23,357
23,35722,67720,14624,72917,78118,24116,30213,07711,51410,40211,45711,40110,59114,48716,3568,3978,0307,6746,3337,0727,036
       Accounts payable 
3,718
2,423
1,432
1,728
3,419
3,700
10,048
4,182
3,241
3,745
3,288
4,117
4,172
4,281
4,919
4,700
2,846
4,726
6,211
7,605
5,789
5,7897,6056,2114,7262,8464,7004,9194,2814,1724,1173,2883,7453,2414,18210,0483,7003,4191,7281,4322,4233,718
       Other Current Liabilities 
82
1,185
739
205
93
85
93
311
173
177
245
178
324
239
229
928
261
271
263
294
357
3572942632712619282292393241782451771733119385932057391,18582
   > Long-term Liabilities 
41
520
471
793
735
679
922
829
701
584
502
407
759
992
1,352
1,214
789
639
433
241
186
1862414336397891,2141,35299275940750258470182992267973579347152041
       Capital Lease Obligations Min Short Term Debt
0
520
471
793
735
679
1,310
1,018
1,107
584
906
773
1,154
1,563
2,001
1,885
1,451
1,334
1,130
955
899
8999551,1301,3341,4511,8852,0011,5631,1547739065841,1071,0181,3106797357934715200
       Long-term Liabilities Other 
41
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000041
> Total Stockholder Equity
60,527
58,363
50,488
78,685
162,875
158,785
137,446
120,742
145,465
127,115
137,961
127,848
108,810
113,684
91,218
69,284
48,407
28,931
83,576
63,573
41,219
41,21963,57383,57628,93148,40769,28491,218113,684108,810127,848137,961127,115145,465120,742137,446158,785162,87578,68550,48858,36360,527
   Common Stock
1
1
1
1
2
2
2
2
3
3
3
3
3
4
0
4
0
0
0
0
0
000004043333322221111
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
-1,804
-1,373
-1,682
-1,608
-1,752
-4,112
-1,121
-1,398
-800
-252
-310
-660
-386
3,035
0
3,982
0
0
0
0
0
000003,98203,035-386-660-310-252-800-1,398-1,121-4,112-1,752-1,608-1,682-1,373-1,804



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-99,223
Operating Income-99,223-99,223
 
Operating Expense (+$)
Research Development83,215
Selling General Administrative16,008
Selling And Marketing Expenses-
Operating Expense99,22399,223
 
Net Interest Income (+$)
Interest Income3,075
Interest Expense--
Other Finance Cost-0
Net Interest Income3,075
 
Pretax Income (+$)
Operating Income-99,223
Net Interest Income3,075
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-93,612-101,759
EBIT - interestExpense = 0
-93,612
-93,612
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--93,612
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-93,612
Tax Provision--
Net Income From Continuing Ops-93,612-93,612
Net Income-93,612
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net2,536-3,075
 

Technical Analysis of Immunic Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Immunic Inc. The general trend of Immunic Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Immunic Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Immunic Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.9505 < 0.964 < 1.124.

The bearish price targets are: 1 > 1 > 0.88.

Tweet this
Immunic Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Immunic Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Immunic Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Immunic Inc. The current macd is -0.00373397.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Immunic Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Immunic Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Immunic Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Immunic Inc Daily Moving Average Convergence/Divergence (MACD) ChartImmunic Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Immunic Inc. The current adx is 20.36.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Immunic Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Immunic Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Immunic Inc. The current sar is 0.894.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Immunic Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Immunic Inc. The current rsi is 62.80. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Immunic Inc Daily Relative Strength Index (RSI) ChartImmunic Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Immunic Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Immunic Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Immunic Inc Daily Stochastic Oscillator ChartImmunic Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Immunic Inc. The current cci is 314.88.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Immunic Inc Daily Commodity Channel Index (CCI) ChartImmunic Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Immunic Inc. The current cmo is 43.07.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Immunic Inc Daily Chande Momentum Oscillator (CMO) ChartImmunic Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Immunic Inc. The current willr is -5.23809524.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Immunic Inc Daily Williams %R ChartImmunic Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Immunic Inc.

Immunic Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Immunic Inc. The current atr is 0.04788215.

Immunic Inc Daily Average True Range (ATR) ChartImmunic Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Immunic Inc. The current obv is -196,038.

Immunic Inc Daily On-Balance Volume (OBV) ChartImmunic Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Immunic Inc. The current mfi is 52.04.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Immunic Inc Daily Money Flow Index (MFI) ChartImmunic Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Immunic Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-26 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-15 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-29 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-30 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-02 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-05 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-11 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-12 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-13 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-17 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-02 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-08 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-17 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-10 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-17 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-18 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Immunic Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Immunic Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.801
Ma 20Greater thanMa 500.944
Ma 50Greater thanMa 1001.008
Ma 100Greater thanMa 2001.125
OpenGreater thanClose0.948
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Immunic Inc with someone you think should read this too:
  • Are you bullish or bearish on Immunic Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Immunic Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Immunic Inc

I send you an email if I find something interesting about Immunic Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Immunic Inc.

Receive notifications about Immunic Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.